{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:34:16Z","timestamp":1764401656400,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ajic.2015.05.027","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T23:38:13Z","timestamp":1435880293000},"page":"1053-1060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-7884","authenticated-orcid":false,"given":"G.J.","family":"Baracco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Eisert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-8815","authenticated-orcid":false,"given":"P.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.R.","family":"Ortega-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2015.05.027_bib1","first-page":"98","article-title":"Summary of notifiable diseases, 2012","volume":"61","year":"2014","journal-title":"MMWR"},{"key":"10.1016\/j.ajic.2015.05.027_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.027_bib3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A\u00a0population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajic.2015.05.027_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ajic.2011.02.006","article-title":"Management and outcome of a varicella exposure in a neonatal intensive care unit: lessons for the vaccine era","volume":"39","author":"Kellie","year":"2011","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2015.05.027_bib5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/590358","article-title":"An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients","volume":"29","author":"Adler","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.027_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/502187","article-title":"A\u00a0cluster of primary varicella cases among healthcare workers with false-positive varicella zoster titers","volume":"24","author":"Behrman","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.027_bib7","first-page":"21","article-title":"Immunization of health-care personnel. Recommendations of the advisory committee on immunization practices (ACIP)","volume":"60","year":"2011","journal-title":"MMWR"},{"year":"2011","series-title":"2010 employee occupational health program survey","author":"Department of Veterans Affairs","key":"10.1016\/j.ajic.2015.05.027_bib8"},{"key":"10.1016\/j.ajic.2015.05.027_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S002217240001456X","article-title":"A\u00a0study of herpes zoster particularly in its relationship to chickenpox","volume":"47","author":"Seiler","year":"1949","journal-title":"J\u00a0Hyg (Lond)"},{"key":"10.1016\/j.ajic.2015.05.027_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1086\/647206","article-title":"Prevention and control of varicella-zoster infections in health care facilities","volume":"17","author":"Weber","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.027_bib11","doi-asserted-by":"crossref","first-page":"ofv006","DOI":"10.1093\/ofid\/ofv006","article-title":"Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009\u20132010","volume":"2","author":"Lebo","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.027_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jviromet.2008.09.032","article-title":"Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals","volume":"155","author":"Chris Maple","year":"2009","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.ajic.2015.05.027_bib13","unstructured":"Centers for Medicare & Medicaid Services. 2012 Clinical laboratory fee schedule. Available from: www.cms.gov\/Medicare\/Medicare-fee-for-Service-Payment\/ClinicalLabFeeSched\/clinlab.html. Accessed November 16,\u00a02012."},{"key":"10.1016\/j.ajic.2015.05.027_bib14","unstructured":"Centers for Disease Control and Prevention. Vaccines for children program (VFC). Available from: www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html#f5. Accessed November 16,\u00a02012."},{"key":"10.1016\/j.ajic.2015.05.027_bib15","unstructured":"Veterans Health Administration. Pharmacy benefits management service. Drugs and pharmaceuticals prices. Internal VA administrative data. Accessed November 16,\u00a02012."},{"key":"10.1016\/j.ajic.2015.05.027_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2105\/AJPH.78.1.19","article-title":"Impact and costs of varicella prevention in a university hospital","volume":"78","author":"Weber","year":"1988","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajic.2015.05.027_bib17","unstructured":"Bureau of Labor Statistics. Employer Costs for Employee Compensation. Table 3. Registered Nurses, 2012. Available from: http:\/\/www.bls.gov\/ncs\/ect\/sp\/ececqrtn.pdf. Accessed November 16, 2012."},{"key":"10.1016\/j.ajic.2015.05.027_bib18","first-page":"609","article-title":"Evolution of varicella surveillance--selected states, 2000-2010","volume":"61","author":"Din","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.ajic.2015.05.027_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/501663","article-title":"Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers","volume":"20","author":"Qureshi","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.027_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S0950268897007887","article-title":"An economic analysis of varicella vaccination for health care workers","volume":"119","author":"Gray","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ajic.2015.05.027_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/647656","article-title":"Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers","volume":"18","author":"Nettleman","year":"1997","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.027_bib22","first-page":"405","article-title":"Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits","volume":"18","author":"Tennenberg","year":"1997","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2015.05.027_bib23","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2005.06.004","article-title":"Cost-effectiveness of varicella vaccination of healthcare workers","volume":"23","author":"Chodik","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ajic.2015.05.027_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/infdis\/jir115","article-title":"Health care-associated measles outbreak in the United States after an importation: challenges and economic impact","volume":"203","author":"Chen","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajic.2015.05.027_bib25","unstructured":"Merck & Co. Highlights of prescribing information. Revised 2012. Available from: www.merck.com\/product\/usa\/pi_circulars\/v\/varivax\/varivax_pi.pdf. Accessed July 31,\u00a02013."},{"key":"10.1016\/j.ajic.2015.05.027_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2009-1653","article-title":"Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated","volume":"125","author":"Sugerman","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2015.05.027_bib27","unstructured":"Bureau of Labor Statistics. May 2011 National occupational employment and wage estimates. United States. Available from: http:\/\/www.bls.gov\/oes\/2011\/may\/oes_nat.htm#29-0000. Accessed November 16,\u00a02012."}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655315006161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655315006161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:42:51Z","timestamp":1759297371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655315006161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0196655315006161"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2015.05.027","relation":{},"ISSN":["0196-6553"],"issn-type":[{"type":"print","value":"0196-6553"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2015.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}